National Infusion Center Association
- Vascular Access
- Uncategorized
- Training
- Storytelling
- Sponsored
- Scheduling
- Risk Management
- Regulatory Comment
- Providers
- Press Release
- Pharmacology
- Patients
- Operations
- Legislative Comment
- Legal Risk Mitigation
- Legal
- Insurance
- Infusion Patients
- In The News
- Emergency Resources
- Disease Management
- Data Management
- Chronic Illness
- Billing
- Artificial Intelligence
- Advocacy
- Access Issues
AUSTIN, Texas, August –, 2026 — The National Infusion Center Association (NICA) is urging Congress to pass H.R. 4299, the Protecting Patient Access to Cancer and Complex Therapies Act (PACTA), before Medicare’s first negotiated prices for Part B drugs take effect in 2028.
In August 2026, NICA submitted comments to Senator Bill Cassidy, MD (R-La.) regarding his discussion draft of the 340B Drug Pricing Integrity and Affordability for Patients […]
In August 2026, NICA submitted comments to the House Republican and Democratic Doctors Caucuses on ways to strengthen Medicare’s physician payment system. NICA emphasized that more stable […]
In August 2026, NICA submitted comments to the Senate Finance Committee on proposals to lower prescription drug costs. NICA highlighted several policies that can affect what […]
In August 2026, NICA submitted comments to the Centers for Medicare & Medicaid Services (CMS) on proposed changes to the Medicare Drug Price Negotiation Program. NICA […]
The data your AI needs already exists. It's just not connected. Learn why building a Data Spine is the step infusion operators can’t afford to skip.
In 2025, NICA’s advocacy work delivered meaningful wins for non-hospital infusion providers by elevating provider voices, shaping policy debates, and driving real-world results at the state […]
Scale Intake Without Burning Out Your Team: Designing a Data-Driven Capacity Model A common refrain in Infusion, and in all parts of healthcare is: “We’re overwhelmed. […]
There’s much at stake if you are directly or indirectly responsible for moving medications from the manufacturer to a patient. Bryan Johnson goes in depth about the DSCSA […]
